The agreement comes after the Oxford-based firm revealed earlier this month that the extract, consumed as part of lifestyle changes, could lead to improved glycaemic and insulin response to sucrose.
“We are excited to embark on our go-to-market partnership with Lus in Europe,” explains Stephane Ducroux, CEO at Phynova.
“Phynova’s strategy is to partner with market focused experts such as Lus, who have a proven track record of customer intimacy, fast prototyping and turn-key solutions using ingredients with a strong science pedigree like Reducose.”
Reducose is the brand name of Phynova’s white mulberry (Morus alba L.) extract, made from a water extract of M. alba leaves, and used in dietary supplements or directly blended into functional foods and drinks.
Reducose is rich in carbohydrates and protein, as well as vitamins and minerals such as beta-carotene, iron, calcium, and zinc.
They also possess various polyhydroxy alkaloids, stilbenoids (such as resveratrol and oxyresveratrol), flavonoids (including quercetin and kaempferol), and anthocyanins.
While financial details have not been disclosed, the partnership also brings together Lus’ expertise in botanical-based ingredients, which includes algal DHA oil, avocado oil as well as flax seed oil powder.
The Netherlands-based firm recently made available Nataxtin, its range of vegan soft gels containing either 4 or 8 milligrams (mg) of Astaxanthin, a powerful antioxidant found in nature in sea food and algae.
"Ever since the start of the company we have been involved in vegan supplements and the Keto / Low-carb market,” comments René Van Hoorn, Founder & CEO of Lus Health Ingredients.
“Consumers nowadays are simply eating too much carbs and we believe that reducing glucose in the body is a key strategy to improve overall health.
“Our partnership with Phynova allows us to serve our clients with a new solution to support healthy blood sugar levels,” he adds.